Skip to main content

Advertisement

Log in

Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats

Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

We previously demonstrated the increase of reactive oxygen species (ROS) production and myeloperoxidase (MPO) activity in the small intestine of methotrexate (MTX)-treated rats. In the present study, we investigated the role of ROS modulating intestinal mucosal permeability in this damage.

Method

MTX (20 mg/kg body weight) was administered to rats intravenously. N-Acetylcysteine (NAC; 80 mg/kg body wt), an antioxidant and a precursor of glutathione (GSH) was administered to rats intraperitoneally to investigate the contribution of ROS to the intestinal permeability enhancement. Intestinal permeability was evaluated by determining that of a poorly absorbable marker, fluorescein isothiocyanate-labeled dextran (FD-4; average molecular mass, 4.4 kDa) using the in vitro everted intestine technique. The occurrence of oxidative stress in the small intestine was assayed by measuring chemiluminescence and thiobarbituric acid reactive substances (TBARS) productions in mucosal homogenates of the small intestine.

Results

The mucosal permeability of FD-4 significantly (p < 0.01) increased in MTX-treated rats compared with control rats, as demonstrated by a twofold increase of FD-4 permeation clearance. This suggests an increase in paracellular permeability. Interestingly, the ROS production was observed preceding the increase of paracellular permeability. Treatment with NAC prevented the MTX-induced ROS production and the increase of paracellular permeability.

Conclusions

NAC protected the small intestine of rats from MTX-induced change in paracellular permeability, suggesting that ROS played an important role in the enhanced paracellular permeability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Thomas HJ (1987) Searching for magic bullet: early approaches to chemotherapy-antifolate, methotrexate. Cancer Res 47:5528–5536

    Google Scholar 

  2. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative therapy. Cancer 49:1221–1230

    Article  CAS  PubMed  Google Scholar 

  3. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P (1998) The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 25:36–43

    CAS  PubMed  Google Scholar 

  4. Taminiau JA, Gall DG, Hamilton JR (1980) Response of the rat small-intestine epithelium to methotexate. Gut 21:486–492

    Article  CAS  PubMed  Google Scholar 

  5. Pinkerton CR, Cameron CH, Sloan JM, Glasgow JF, Gwevava NJ (1980) Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblatic leukaemia. J Clin Pathol 35:1272–1277

    Article  Google Scholar 

  6. Beck PL, Wong JF, Li Y, Swaminathan S, Xavier RJ, Devaney KL, Podolsky DK (2004) Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126:796–808

    Article  CAS  PubMed  Google Scholar 

  7. Khan SA, Wingard JR (2001) Infection and mucosal injury in cancer treatment. NCI Monogr 29:31–36

    Google Scholar 

  8. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831

    Article  CAS  PubMed  Google Scholar 

  9. Gibson RJ, Keefe DM, Clarke JM, Regester GO, Thompson FM, Goland GJ, Edwards BG, Cummins AG (2002) The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol 50:53–58

    Article  CAS  PubMed  Google Scholar 

  10. Howarth GS, Cool JC, Bourne AJ, Ballard FJ, Read LC (1998) Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 15:279–292

    Article  CAS  PubMed  Google Scholar 

  11. Jahovic N, Sener G, Cevik H, Ersoy Y, Arbak S, Yegen BC (2004) Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem Funct 22:169–178

    Article  CAS  PubMed  Google Scholar 

  12. Tsurui K, Kosakai Y, Horie T, Awazu S (1990) Vitamin A protects the small intestine from methotrexate-induced damage in rats. J Pharmacol Exp Ther 253:1278–1284

    CAS  PubMed  Google Scholar 

  13. Horie T, Nakamaru M, Masubuchi Y (1998) Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sci 62:1333–1338

    Article  CAS  PubMed  Google Scholar 

  14. Horie T, Matsumoto H, Kasagi M, Sugiyama A, Kikuchi M, Karasawa C, Awazu S, Itakura Y, Fuwa T (1999) Protective effect of aged garlic extract on the small intestinal damage of rats induced by methotrexate administration. Planta Med 65:545–548

    Article  CAS  PubMed  Google Scholar 

  15. Gao F, Nakamaru M, Masubuchi Y, Horie T (2001) Protective effect of a synthetic analog of prostaglandin E1 on the small intestinal damage induced by the administration of methotexate to rats. J Pharm Sci 90:1040–1048

    Article  CAS  PubMed  Google Scholar 

  16. Miyazono Y, Gao F, Horie T (2004) Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol 39:1119–1127

    Article  CAS  PubMed  Google Scholar 

  17. Gao F, Ueda S, Horie T (2001) Effect of a synthetic analog of prostaglandin E1 on the intestinal mucosa of methotrexate-treated rats. Anticancer Res 21:1913–1917

    CAS  PubMed  Google Scholar 

  18. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025

    Article  PubMed  Google Scholar 

  19. Quiles JL, Huertas JR, Battino M, Mataix J, Ramirez-Tortosa MC (2002) Antioxidant nutrients and adriamycin toxicity. Toxicology 180:79–95

    Article  CAS  PubMed  Google Scholar 

  20. Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37:1–18

    Article  CAS  PubMed  Google Scholar 

  21. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H (2001) Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27–34

    Article  CAS  PubMed  Google Scholar 

  22. Hagiwara SI, Ishii Y, Kitamura S (2000) Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 162:225–231

    CAS  PubMed  Google Scholar 

  23. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47–95

    CAS  PubMed  Google Scholar 

  24. Nakamaru M, Masubuchi Y, Narimatsu S, Awazu S, Horie T (1998) Evaluation of damaged small intestine of mouse following methotrexate administration. Cancer Chemother Pharmacol 41:98–102

    Article  CAS  PubMed  Google Scholar 

  25. Gao F, Horie T (2002) A synthetic analog of prostaglandin E(1) prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate-treated rats. Life Sci 71:1091–1099

    Article  CAS  PubMed  Google Scholar 

  26. Sheth P, Basuroy S, Li C, Naren AP, Rao RK (2003) Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem 278:49239–49245

    Article  CAS  PubMed  Google Scholar 

  27. Rao RK, Basuroy S, Rao VU, Karnaky KJ Jr, Gupta A (2002) Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 368(Pt 2):471–481

    Article  CAS  PubMed  Google Scholar 

  28. Edens HA, Levi BP, Jaye DL, Walsh S, Reaves TA, Turner JR, Nusrat A, Parkos CA (2002) Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration. J Immunol 169:476–486

    CAS  PubMed  Google Scholar 

  29. Zen K, Parkos CA (2003) Leukocyte-epithelial interactions. Curr Opin Cell Biol 15:557–564

    Article  CAS  PubMed  Google Scholar 

  30. Doluisio JT, Billups NF, Dittert LW, Sugita ET, Swintosky JV (1969) Drug absorption I: an in situ rat gut technique yielding realistic absorption rates. J Pharm Sci 58:1196–1200

    Article  CAS  PubMed  Google Scholar 

  31. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310

    Article  CAS  PubMed  Google Scholar 

  32. Hartsok A, Nelson WJ (2008) Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 1778:660–669

    Article  Google Scholar 

  33. Li T, Ito K, Sumi S-I, Fuwa T, Horie T (2005) Antiapoptosis action of aged garlic extract (AGE) protects epithelial cells from methotrexate induced injury. Gut 54:1819–1820

    Article  CAS  PubMed  Google Scholar 

  34. Li T, Ito K, Sumi S-I, Fuwa T, Horie T (2009) Protective effect of aged garlic extract (AGE) on the apoptosis of intestinal epithelial cells caused by methotrexate. Cancer Chemother Pharmacol 63:873–880

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshiharu Horie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maeda, T., Miyazono, Y., Ito, K. et al. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats. Cancer Chemother Pharmacol 65, 1117–1123 (2010). https://doi.org/10.1007/s00280-009-1119-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-009-1119-1

Keywords

Navigation